Select Page

IDHIFA (enasidenib) tablets, for oral use. Initial U.S. Approval: 2017

IDHIFA (enasidenib) tablets, for oral use. Initial U.S. Approval: 2017

Medicines for medicine used to treat people with acute myeloid leukemia (AML) treatment.
IDHIFA is a Anti Cancer medicine medicine. IDHIFA is used to treat blood cancer (such as chronic lymphocytic leukemia, follicular lymphoma).
IDHIFA is an isocitrate dehydrogenase-2 inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA approved test.
Tablets: 50 mg or 100 mg
Manufactured By: Celgene Corporation
Prescribing Information URL: Click Here

Procedure to buy IDHIFA ® (enasidenib) tablets?
To buy IDHIFA ® (enasidenib) tablets, patients can simply fill the order form or can send mail at or can also send Whatsapp message at +91 96677 50889. You will get reply within few hours with pricing and procedure details. Note:- the order will be confirmed only after the receipt of valid prescription of doctor.


Enasidenib (INN; trade name Idhifa) is a medication used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test. It is an inhibitor of IDH2. It was developed by Agios Pharmaceuticals and is licensed to Celgene for further development. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.


  1. Doctor’s Prescription – We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.
  2. Patient’s Medical history – We would require all test reports and medical reports of the patient for last 3 months.
  3. Patient’s Identity card – We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

For Overseas Patient

Can I get anti-cancer medicines even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Bionique Healthcare can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of –

IDHIFA (enasidenib) tablets in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
IDHIFA (enasidenib) tablets in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
IDHIFA (enasidenib) tablets in North America – Mexico.
IDHIFA (enasidenib) tablets in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
IDHIFA (enasidenib) tablets in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
IDHIFA (enasidenib) tablets in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
IDHIFA (enasidenib) tablets in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
IDHIFA (enasidenib) tablets in Australia and New Zealand.

For Indian Patient

Ani-Cancer IDHIFA (enasidenib) tablets are prescription drug. 

We facilitate by-

  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable source in USA, Europe and Japan.
  • Ensuring 100% transparency.

IDHIFA (enasidenib) tablets can be shipped to Ahmedabad, Bangalore, Chennai, Cochin, Hyderabad, Delhi, Haryana, Jaipur, Jammu and Kashmir, Himachal Pradesh, Kolkata, Lucknow, Mumbai, Pune, Punjab and other cities in India. Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. 


There are no reviews yet.

Be the first to review “IDHIFA (enasidenib) tablets, for oral use. Initial U.S. Approval: 2017”

Your email address will not be published.

Anti-Cancer Medicine Supplier.

Bionique Healthcare is a consulting pharmaceutical company which assist Patients in accessing medicines in India. Bionique Healthcare facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact Bionique at +91 9667750889 or write to at –

Product Disclaimer

Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturer or licensee. 

Bionique Healthcare does not lay any claim on them.